S-nitrosothiol donor compounds could be a novel therapeutic intervention in ALS and other neurodegenerative disorders with S-nitrosothiol depletion, as the repletion of intracellular S-nitrosothiol levels with S-nitrosothiol donor compounds rescued mutant-SOD1-induced cell death [247]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.